BHVN
Price
$54.65
Change
-$2.36 (-4.14%)
Updated
Mar 28, 6:59 PM EST
42 days until earnings call
XNCR
Price
$22.13
Change
-$0.29 (-1.29%)
Updated
Mar 28, 6:59 PM EST
41 days until earnings call
Ad is loading...

Analysis and predictions BHVN vs XNCR

Header iconBHVN vs XNCR Comparison
Open Charts BHVN vs XNCRBanner chart's image
Biohaven
Price$54.65
Change-$2.36 (-4.14%)
Volume$174.44K
CapitalizationN/A
Xencor
Price$22.13
Change-$0.29 (-1.29%)
Volume$286.33K
CapitalizationN/A
View a ticker or compare two or three
BHVN vs XNCR Comparison Chart

Loading...

BHVNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XNCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BHVN vs. XNCR commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a StrongSell and XNCR is a Buy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (BHVN: $54.69 vs. XNCR: $22.10)
Brand notoriety: BHVN and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 71% vs. XNCR: 55%
Market capitalization -- BHVN: $4.47B vs. XNCR: $1.35B
BHVN [@Biotechnology] is valued at $4.47B. XNCR’s [@Biotechnology] market capitalization is $1.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both BHVN and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 3 TA indicator(s) are bullish while XNCR’s TA Score has 6 bullish TA indicator(s).

  • BHVN’s TA Score: 3 bullish, 5 bearish.
  • XNCR’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than BHVN.

Price Growth

BHVN (@Biotechnology) experienced а -2.13% price change this week, while XNCR (@Biotechnology) price change was -3.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

BHVN is expected to report earnings on May 10, 2024.

XNCR is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BHVN with price predictions.
OPEN
A.I.dvisor published
a Summary for XNCR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BHVN($4.47B) has a higher market cap than XNCR($1.35B). BHVN YTD gains are higher at: 27.780 vs. XNCR (4.098). XNCR has higher annual earnings (EBITDA): -127.14M vs. BHVN (-429.14M). XNCR has more cash in the bank: 594M vs. BHVN (382M). BHVN has less debt than XNCR: BHVN (30.9M) vs XNCR (83.4M). XNCR has higher revenues than BHVN: XNCR (168M) vs BHVN (0).
BHVNXNCRBHVN / XNCR
Capitalization4.47B1.35B331%
EBITDA-429.14M-127.14M338%
Gain YTD27.7804.098678%
P/E RatioN/A72.46-
Revenue0168M-
Total Cash382M594M64%
Total Debt30.9M83.4M37%
FUNDAMENTALS RATINGS
BHVN vs XNCR: Fundamental Ratings
BHVN
XNCR
OUTLOOK RATING
1..100
7559
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
79
Overvalued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
3562
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHVN's Valuation (65) in the Pharmaceuticals Major industry is in the same range as XNCR (79) in the Biotechnology industry. This means that BHVN’s stock grew similarly to XNCR’s over the last 12 months.

BHVN's Profit vs Risk Rating (91) in the Pharmaceuticals Major industry is in the same range as XNCR (100) in the Biotechnology industry. This means that BHVN’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's SMR Rating (94) in the Biotechnology industry is in the same range as BHVN (98) in the Pharmaceuticals Major industry. This means that XNCR’s stock grew similarly to BHVN’s over the last 12 months.

BHVN's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as XNCR (62) in the Biotechnology industry. This means that BHVN’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's P/E Growth Rating (7) in the Biotechnology industry is significantly better than the same rating for BHVN (100) in the Pharmaceuticals Major industry. This means that XNCR’s stock grew significantly faster than BHVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHVNXNCR
RSI
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 9 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
BHVNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XNCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIICX16.340.06
+0.37%
AlphaCentric Strategic Income C
JACCX36.72N/A
N/A
Janus Henderson Forty C
MNDRX21.69N/A
N/A
MFS New Discovery R2
MSTFX10.41N/A
N/A
Morningstar International Equity
GSBGX24.57N/A
N/A
GMO Small Cap Quality Fund Class VI

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
-4.09%
VCYT - BHVN
43%
Loosely correlated
+1.84%
MRSN - BHVN
39%
Loosely correlated
-0.22%
FOLD - BHVN
38%
Loosely correlated
-0.93%
ROIV - BHVN
36%
Loosely correlated
-2.77%
NTLA - BHVN
36%
Loosely correlated
+1.67%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-1.43%
BEAM - XNCR
54%
Loosely correlated
-2.71%
PRME - XNCR
53%
Loosely correlated
+3.48%
VCYT - XNCR
52%
Loosely correlated
+1.84%
DNLI - XNCR
52%
Loosely correlated
-1.30%
NTLA - XNCR
51%
Loosely correlated
+1.67%
More